Form 4 for NUVB Nuvation Bio Inc.
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-20 · accession 0001521111-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-24 | 2025-11-20 | NUVB | Hattersley Gary | CSO | M - OptEx | $1.90 | +369.1K | 300.0K | New | +$702.1K |
| DM | 2025-11-24 | 2025-11-20 | NUVB | Hattersley Gary | CSO | S - Sale+OE | $7.23 | -369.1K | 0 | -100% | -$2.67M |
| DM | 2025-11-24 | 2025-11-20 | NUVB | Hattersley Gary | CSO | M - OptEx | $0.00 | -369.1K | 200.0K | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-11-20 | M | A | 69,051 | $1.74 | 69,051 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-11-20 | S | D | 69,051 | $7.23 | 0 | D | — | — | (F1) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2025-11-20 | M | A | 300,000 | $1.94 | 300,000 | D | — | — | |
| 4 | Common | Class A Common Stock | 2025-11-20 | S | D | 300,000 | $7.23 | 0 | D | — | — | (F1) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-11-20 | M | D | 69,051 | $0.00 | 229,884 | D | $1.74 · — to 2030-01-21 | 69,051 Class A Common Stock | (F2) Options vested as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-11-20 | M | D | 300,000 | $0.00 | 200,000 | D | $1.94 · — to 2033-02-27 | 300,000 Class A Common Stock | (F3) Options vested as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. |